ASCENDIS PHARMA

ascendis-pharma-logo

Ascendis Pharma has built a high value pipeline with the aim of changing clinical treatment paradigms. Using our innovative TransCon prodrug technology platform, we continue to identify new opportunities addressing areas of high unmet medical need. TransCon is applicable to all drug classes, and is currently being used to create superior prodrugs of proteins, peptides and small molecules. Depending on choice of TransCon Carrier, either systemic or localized drug exposure is achieved, while dosin... g frequency is determined by the choice of TransCon Linker. The prodrugs are new chemical entities with new patent life. Product development process is de-risked, as the prodrugs release the active component in its native and unmodified form, maintaining the original drug’s well known mode of action.

#SimilarOrganizations #People #Financial #Website #More

ASCENDIS PHARMA

Social Links:

Industry:
Biotechnology Clinical Trials Health Care

Founded:
2006-01-01

Address:
Palo Alto, California, United States

Country:
United States

Website Url:
http://www.ascendispharma.com

Total Employee:
501+

Status:
Active

Contact:
650 352 8389

Email Addresses:
[email protected]

Total Funding:
1.43 B USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon WordPress Content Delivery Network Global Site Tag HSTS IPv6 Organization Schema


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

carebox-healthcare-logo

Carebox Healthcare

Carebox connects patients and physicians exploring treatment options with clinical trials.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

press-ganey-logo

Press Ganey

Press Ganey offers an integrated suite of solutions that enable enterprise transformation across the patient journey.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

vbi-vaccines-logo

VBI Vaccines

VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.

Current Employees Featured

not_available_image

Harald Rau
Harald Rau Senior Vice President, Chief Scientific Officer @ Ascendis Pharma
Senior Vice President, Chief Scientific Officer

birgitte-volck_image

Birgitte Volck
Birgitte Volck Non Executive Director @ Ascendis Pharma
Non Executive Director
2016-05-01

michael-wolff-jensen_image

Michael Wolff Jensen
Michael Wolff Jensen Chairman Of The Board Of Directors @ Ascendis Pharma
Chairman Of The Board Of Directors
2008-01-01

jan-møller-mikkelsen_image

Jan Møller Mikkelsen
Jan Møller Mikkelsen Co-Founder, President and CEO @ Ascendis Pharma
Co-Founder, President and CEO

lotte-sønderbjerg_image

Lotte Sønderbjerg
Lotte Sønderbjerg SVP Chief Administrative Offer Managing Director Ascendis GmbH @ Ascendis Pharma
SVP Chief Administrative Offer Managing Director Ascendis GmbH
2007-12-01

Founder


jan-møller-mikkelsen_image

Jan Møller Mikkelsen

Stock Details


Company's stock symbol is NASDAQ:ASND

Acquisitions List

Date Company Article Price
2007-12-13 Complex Biosystems Complex Biosystems acquired by Ascendis Pharma N/A

Investors List

royalty-pharma_image

Royalty Pharma

Royalty Pharma investment in Post-IPO Debt - Ascendis Pharma

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Post-IPO Equity - Ascendis Pharma

venrock_image

Venrock

Venrock investment in Series D - Ascendis Pharma

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series D - Ascendis Pharma

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series D - Ascendis Pharma

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series D - Ascendis Pharma

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series D - Ascendis Pharma

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series D - Ascendis Pharma

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Series A - Ascendis Pharma

technostart_image

TechnoStart

TechnoStart investment in Series A - Ascendis Pharma

Investments List

Date Company Article Money raised
2021-01-08 Visen Pharmaceuticals Ascendis Pharma investment in Series B - Visen Pharmaceuticals 150 M USD
2018-11-13 Visen Pharmaceuticals Ascendis Pharma investment in Series A - Visen Pharmaceuticals 40 M USD

Official Site Inspections

http://www.ascendispharma.com Semrush global rank: 1.79 M Semrush visits lastest month: 12.53 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ascendis Pharma"

About Us - Ascendis Pharma

Build integrated commercial organization in North America and select European countries; Establish global commercial presence through partners with local expertise and infrastructure in other geographic areas; ... You are about to …See details»

Careers - Ascendis Pharma

We are committed to working with and providing reasonable accommodations to job applicants with disabilities. If you have a disability that limits your ability to apply for a position through our …See details»

Ascendis Pharma: We’ve got making a difference for patients …

We apply our TransCon technology platform to build a leading, fully integrated biopharma company & make a meaningful difference for patients, caregivers & HCPs.See details»

Investors & News | Ascendis Pharma

Nov 7, 2024 Ascendis Pharma is applying our innovative TransConâ„¢ technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful …See details»

Ascendis Pharma - LinkedIn

Ascendis Pharma Biotechnology Research Hellerup, Capital Region of Denmark 60,342 followers Committed to making a meaningful difference for patientsSee details»

Pendopharm signs exclusive distribution agreement with Ascendis …

Montreal, July 9, 2024 – Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S (NASDAQ: ASND) …See details»

Ascendis Pharma Company Profile | Management and Employees …

SQL International Organization for Standardization . Other IT Infrastructure Software (5 Technologies) Open AI . Redwood Software Reference Solutions . IT Lab IT Lab . ...See details»

Ascendis Pharma - Crunchbase Company Profile

Organization. Ascendis Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment …See details»

Sustainability & P|ESG Report 2023 - Ascendis Pharma

Multifaceted organization to support our ongoing commercialization and serve as foundation for future Endocrinology Rare Disease product launches. We are furthermore expanding our …See details»

Ascendis Pharma - Overview, News & Similar companies - ZoomInfo

Jul 26, 2024 www.ascendispharma.com. Revenue $352.6 Million. Stock Symbol ASND. Industry Pharmaceuticals Healthcare . Most Recent Scoops. Aug 14 2024. Hiring Plans. Jul 27 2024. …See details»

Leadership - Ascendis Pharma

Sherrie Glass was named Chief Business Officer at Ascendis Pharma in September 2024. Prior to joining Ascendis, Ms. Glass was Senior Vice President of Enterprise Strategy & Operational …See details»

Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual …

Jan 11, 2021 The company’s US commercial organization is in place and commercial manufacturing is ongoing for the potential launch of lonapegsomatropin in pediatric GHD …See details»

About Us - Ascendis Pharma US

Build integrated commercial organization in North America and select European countries; ... You are about to access www.ascendispharma.com. Click below if you wish to proceed. GO …See details»

Corporate Responsibility - Ascendis Pharma

OUR APPROACH to CORPORATE RESPONSIBILITY. As a company committed to making a difference in the lives of patients, responsible corporate governance supports our business …See details»

Ascendis Pharma A/S Announces Planned Board Transition

“With the company transitioning from a developmental stage company to a global commercial organization, I want to focus my efforts on serving my role as the Company’s Chief Legal …See details»

Ascendis Pharma - Overview, News & Similar companies - ZoomInfo

Www.ascendispharma.jp. Revenue $10.3 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. No recent news or media. Overview ; Who is Ascendis Pharma. Ascendis …See details»

Ascendis Pharma A/S Announces New Commercial Endocrinology …

May 23, 2022 Reflecting on his time at Ascendis, Mr. Høiland said, “It has been a privilege to establish the Ascendis endocrinology commercial organization and launch SKYTROFA in the …See details»

Ascendis Pharma A/S

Jan 7, 2024 • Expanding reach for SKYTROFA through Ascendis commercial organization building on therapeutic synergies • Full year 2024 SKYTROFA revenue expected to be €320 …See details»

linkstock.net © 2022. All rights reserved